Jump to content

Recommended Posts

Posted

https://medicalxpress.com/news/2020-07-hiv-drug-year.html

 

Beyond that, he noted, longer-acting drugs could potentially offer a simpler way to prevent HIV in high-risk people: Right now, that's done with a daily pill regimen known as PrEP (pre-exposure prophylaxis).

However, much more work remains ahead. The new study, published July 1 in the journal Nature, offers a "proof of principle" that a dosing interval of every six months is possible, Rhee said.

The researchers found that in 40 healthy people, lenacapavir appeared safe and could remain active in the body for more than six months. And in 32 people with previously untreated HIV, a single injection reduced viral levels in the blood within nine days.

It's encouraging that the drug is "amenable to dosing every six months," said Dr. Rajesh Gandhi, an infectious disease physician at Massachusetts General Hospital, in Boston.

Gandhi, who is also chair-elect of the HIV Medicine Association, agreed there is a need for longer-acting HIV drugs.

The catch is that HIV is not treated with one drug alone—to keep the virus suppressed and limit the chances of it becoming resistant to medication.

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.



×
×
  • Create New...